Evommune, Inc. (EVMN)
NYSE · Healthcare
Evommune, Inc. Income Statement 2024–2025
| Dec 2025 | Dec 2024 | |
|---|---|---|
| Revenues | ||
| Revenue | 13.0M | 7.0M |
| Gross Profit | — | — |
| Profitability | ||
| Operating Income | -81.1M | -70.0M |
| EBITDA | -80.5M | -69.5M |
| Net Income | -68.9M | -66.8M |
| Per Share Data | ||
| EPS (diluted) | $-11.22 | $-45.29 |
| Shares Outstanding (dil.) | 6M | 2M |
Evommune, Inc. Income Statement — FAQ
Evommune, Inc. (EVMN) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EVMN's income statement history?
The chart and table above show Evommune, Inc.'s income statement by year and by quarter, including the growth rate.